More recently, it has been found that Tregs (CD4+CD25+FoxP3+) can act to limit Ang II–induced inflammation and damage in the vasculature and heart, thereby reducing the extent of hypertension and cardiac remodeling (36–40). This evidence concerns the gene IL2RA and Hypertension.